Palo Alto Networks Inc vs Pfizer Inc — how do they compare? Palo Alto Networks Inc trades at $335.38 (market cap $278.85B), while Pfizer Inc trades at $24.91 (market cap $142.14B). The key difference: Palo Alto Networks Inc is the larger of the two by market cap, and Pfizer Inc pays a 6.9% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals.
| PANW | PFE | |
|---|---|---|
Market Cap | $278.85B | $142.14B |
Sector | Technology | Health |
52-Week High | $358.68 | $28.56 |
52-Week Low | $141.67 | $23.29 |
Enterprise Value | $277.81B | $192.80B |
Volume | — | 29,869,932 |
Dividend Yield | — | 6.9% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
Trailing returns across standard periods
Latest headlines on both assets
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →